JASPER THERAPEUTICS INC

Jasper Therapeutics Shares Rise 4.82% as Shareholder Meeting Sets Strategic Moves for 2026

Jasper Therapeutics shares climb 4.82% as board plans reverse split, preferred‑stock conversion, and Kira Pharma acquisition unveiled.

JASPER THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 22:03

3 minutes to read

Jasper Therapeutics (JSPR) Slides 0.62% as Biotech Volatility Rises: Key Outlook for Investors

Jasper Therapeutics dips 0.62% amid biotech volatility, but its under‑priced stem‑cell safety platform and partnership potential hint at upside. Click to learn more.

JASPER THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

21/10/2026, 01:40

3 minutes to read